FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996197850> ?p ?o ?g. }

• W1996197850 endingPage "412" @default.
• W1996197850 startingPage "404" @default.
• W1996197850 abstract "Panic disorder is an anxiety disorder that can be treated by long-term administration of tricyclic antidepressants such as imipramine, monoamine oxidase inhibitors such as phenelzine, or the selective serotonin reuptake inhibitor (SSRI) antidepressants. Clinical data also indicate that some benzodiazepines, such as alprazolam, are effective antipanic agents, and that their therapeutic onset is faster than that of antidepressants. Benzodiazepines are well known for their action at GABA(A) receptors, and preclinical data indicate that imipramine and phenelzine also interfere with the GABAergic system. In addition some clinical data lend support to decreased benzodiazepine-sensitive receptor function in panic disorder patients. Using imipramine, phenelzine and alprazolam, we investigated, in rats, the possibility that the therapeutic efficacy of antipanic agents stems from the remodeling of GABAergic transmission in the pons-medulla region. Of the 12 GABA(A) receptor subunit (alpha 1--6, beta 1--3, gamma 1--3) steady-state mRNA levels investigated, we observed an increase in the levels of the alpha 3-, beta 1- and gamma 2-subunit transcripts with all three antipanic agents tested. The effects of imipramine and phenelzine on these subunits occurred after 21 days of treatment, while alprazolam effects were observed after 3 days of administration. Histochemical data suggest that the alpha 3 beta 1 gamma 2 subunits comprise a receptor subtype in the pons-medulla region. Therefore, we conclude that these molecular events parallel the therapeutic profile of the drugs examined. We further propose that these events may correspond to a remodeling of the GABA(A) receptor population, and may be useful markers for investigation of the antipanic properties of drugs." @default.
• W1996197850 created "2016-06-24" @default.
• W1996197850 creator A5055924518 @default.
• W1996197850 creator A5067692784 @default.
• W1996197850 creator A5088403251 @default.
• W1996197850 creator A5090531404 @default.
• W1996197850 date "2001-07-01" @default.
• W1996197850 modified "2023-10-17" @default.
• W1996197850 title "Common effects of chronically administered antipanic drugs on brainstem GABAA receptor subunit gene expression" @default.
• W1996197850 cites W1524203275 @default.
• W1996197850 cites W1563037009 @default.
• W1996197850 cites W156306960 @default.
• W1996197850 cites W177013919 @default.
• W1996197850 cites W1964439518 @default.
• W1996197850 cites W1965198682 @default.
• W1996197850 cites W1965752072 @default.
• W1996197850 cites W1967581611 @default.
• W1996197850 cites W1967914487 @default.
• W1996197850 cites W1973414784 @default.
• W1996197850 cites W1981896361 @default.
• W1996197850 cites W1981998100 @default.
• W1996197850 cites W1983967908 @default.
• W1996197850 cites W1984577458 @default.
• W1996197850 cites W1996339077 @default.
• W1996197850 cites W1999462458 @default.
• W1996197850 cites W2000204323 @default.
• W1996197850 cites W2006550065 @default.
• W1996197850 cites W2009547998 @default.
• W1996197850 cites W2015781143 @default.
• W1996197850 cites W2018312418 @default.
• W1996197850 cites W2019194252 @default.
• W1996197850 cites W2025083501 @default.
• W1996197850 cites W2026209763 @default.
• W1996197850 cites W2029285692 @default.
• W1996197850 cites W2039738625 @default.
• W1996197850 cites W2045307782 @default.
• W1996197850 cites W2052932636 @default.
• W1996197850 cites W2056223801 @default.
• W1996197850 cites W2058308027 @default.
• W1996197850 cites W2059864318 @default.
• W1996197850 cites W2068629053 @default.
• W1996197850 cites W2068746830 @default.
• W1996197850 cites W2073219926 @default.
• W1996197850 cites W2086079205 @default.
• W1996197850 cites W2088071868 @default.
• W1996197850 cites W2096494544 @default.
• W1996197850 cites W2112979199 @default.
• W1996197850 cites W2118767317 @default.
• W1996197850 cites W2139230578 @default.
• W1996197850 cites W2169230464 @default.
• W1996197850 cites W2320439911 @default.
• W1996197850 cites W2405050690 @default.
• W1996197850 cites W4243164973 @default.
• W1996197850 cites W65306380 @default.
• W1996197850 cites W1995914052 @default.
• W1996197850 doi "https://doi.org/10.1038/sj.mp.4000879" @default.
• W1996197850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11443524" @default.
• W1996197850 hasPublicationYear "2001" @default.
• W1996197850 type Work @default.
• W1996197850 sameAs 1996197850 @default.
• W1996197850 citedByCount "19" @default.
• W1996197850 countsByYear W19961978502012 @default.
• W1996197850 countsByYear W19961978502014 @default.
• W1996197850 countsByYear W19961978502015 @default.
• W1996197850 countsByYear W19961978502018 @default.
• W1996197850 countsByYear W19961978502022 @default.
• W1996197850 crossrefType "journal-article" @default.
• W1996197850 hasAuthorship W1996197850A5055924518 @default.
• W1996197850 hasAuthorship W1996197850A5067692784 @default.
• W1996197850 hasAuthorship W1996197850A5088403251 @default.
• W1996197850 hasAuthorship W1996197850A5090531404 @default.
• W1996197850 hasBestOaLocation W19961978501 @default.
• W1996197850 hasConcept C118552586 @default.
• W1996197850 hasConcept C126322002 @default.
• W1996197850 hasConcept C134018914 @default.
• W1996197850 hasConcept C142724271 @default.
• W1996197850 hasConcept C15744967 @default.
• W1996197850 hasConcept C168258287 @default.
• W1996197850 hasConcept C170493617 @default.
• W1996197850 hasConcept C181199279 @default.
• W1996197850 hasConcept C185592680 @default.
• W1996197850 hasConcept C204787440 @default.
• W1996197850 hasConcept C2776024655 @default.
• W1996197850 hasConcept C2777123777 @default.
• W1996197850 hasConcept C2777196872 @default.
• W1996197850 hasConcept C2777529043 @default.
• W1996197850 hasConcept C2778173252 @default.
• W1996197850 hasConcept C2779145073 @default.
• W1996197850 hasConcept C2779177108 @default.
• W1996197850 hasConcept C2780712732 @default.
• W1996197850 hasConcept C2781073023 @default.
• W1996197850 hasConcept C2781210498 @default.
• W1996197850 hasConcept C2781442855 @default.
• W1996197850 hasConcept C55493867 @default.
• W1996197850 hasConcept C558461103 @default.
• W1996197850 hasConcept C71924100 @default.
• W1996197850 hasConcept C98274493 @default.
• W1996197850 hasConceptScore W1996197850C118552586 @default.

• next